封面
市場調查報告書
商品編碼
1858837

用於航太航太領域的自修復聚合物市場機會、成長促進因素、產業趨勢分析及預測(2025-2034年)

Self-Healing Polymers for Aerospace Applications Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: | 出版商: Global Market Insights Inc. | 英文 184 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球航太航太應用自修復聚合物市場價值為 1.75 億美元,預計到 2034 年將以 13.2% 的複合年成長率成長至 6.032 億美元。

用於航空航太領域的自修復聚合物市場 - IMG1

推動市場成長的動力源自於旨在提升飛機維修效率的聚合物技術進步。自修復聚合物在航太的重要性日益凸顯,因為它們能夠在微裂紋和損傷被檢查人員發現之前進行修復,從而減少頻繁維護的需求。這些技術,例如膠囊填充環氧樹脂、血管化碳纖維增強聚合物(CFRP)和動態共價熱塑性塑膠,已被證明能夠有效延長飛機零件的使用壽命。自修復系統的應用範圍已從塗層擴展到關鍵結構部件,主要的航太企業正在探索將其直接整合到主要結構中,以提高耐久性並減輕重量。隨著法規日益嚴格,尤其是在航太材料對環境影響方面,對自修復聚合物的需求持續成長。歐盟提出的2035年實現50%複合材料可回收利用率的路線圖等最新的永續航空計劃,進一步推動了市場成長。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 1.75億美元
預測值 6.032億美元
複合年成長率 13.2%

預計2025年至2034年間,外置式自癒系統市場將以13%的複合年成長率成長。該市場受益於一種混合方案,結合了艙體、血管和內源性系統,提供了更耐用、更易於製造的解決方案,可將飛機檢查間隔縮短高達15%。這種整合系統有望成為預計於2028年推出的下一代窄體飛機的標準配備。

2024年,商用航空領域的市場規模預計將達到8,970萬美元。在生產初期將自修復技術整合到結構部件中正日益普及。生產效率的提高、數位孿生模型的運用以及更嚴格的損傷容限法規,都大大推動了自修復聚合物的應用。透過從一開始就採用自修復材料,原始設備製造商(OEM)可以實現更可預測的維修週期和長期的成本節約。

2024年,北美航空航太用自修復聚合物市場規模為6,590萬美元,預計2034年將達到2.198億美元。主要驅動力是航太業,特別是美國日益成長的需求,2024年美國市場規模達5,650萬美元。強勁的商用飛機生產產業以及美國軍方對基於狀態的維護的大力推進,都為該市場的發展提供了助力。稅收優惠、研究資助以及完善的維護、修理和大修(MRO)網路正在加速先進自修復技術的應用。

全球航太航太應用自修復聚合物市場的主要企業包括Autonomic Materials Inc.、阿科瑪(Arkema)、贏創工業集團(Evonik Industries AG)、巴斯夫(BASF SE)和索爾維(Solvay SA)。為了鞏固市場地位,這些企業正採取多種策略,包括大力投資研發,以開發更有效率、更經濟的自修復聚合物技術。他們也致力於拓展產品線,將自修復材料直接整合到飛機主要結構中,從而提高耐久性、減輕重量並提升生產效率。這些企業正與航太原始設備製造商(OEM)和供應商建立戰略合作夥伴關係,以確保自修復系統能夠無縫整合到飛機生產線中。此外,這些企業也積極致力於開發永續的生物基材料,以滿足嚴格的環境和監管標準,例如可回收性目標。

目錄

第1章:方法論

  • 市場範圍和定義
  • 研究設計
    • 研究方法
    • 資料收集方法
  • 資料探勘來源
    • 全球的
    • 地區/國家
  • 基準估算和計算
    • 基準年計算
    • 市場估算的關鍵趨勢
  • 初步研究和驗證
    • 原始資料
  • 預測模型
  • 研究假設和局限性

第2章:執行概要

第3章:行業洞察

  • 產業生態系分析
    • 供應商格局
    • 利潤率
    • 每個階段的價值增加
    • 影響價值鏈的因素
    • 中斷
  • 產業影響因素
    • 成長促進因素
      • 生物製劑和生物相似藥的成長
      • 自我管理和居家護理
      • 監管機構推動提高注射器安全性
    • 產業陷阱與挑戰
      • 玻璃分層和破損
      • 嚴格的監管測試
      • 供應鏈的複雜性
    • 市場機遇
      • 聚合物材料創新
      • 智慧型/連網注射器系統
      • 亞太新興市場的需求
  • 成長潛力分析
  • 監管環境
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特的分析
  • PESTEL 分析
  • 價格趨勢
    • 按地區
    • 透過癒合機制
  • 未來市場趨勢
  • 專利格局
  • 貿易統計(HS編碼)(註:僅提供重點國家的貿易統計資料)
    • 主要進口國
    • 主要出口國
  • 永續性和環境方面
    • 永續實踐
    • 減少廢棄物策略
    • 生產中的能源效率
    • 環保舉措
  • 碳足跡考量

第4章:競爭格局

  • 介紹
  • 公司市佔率分析
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區
      • 拉丁美洲
      • MEA
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 關鍵進展
    • 併購
    • 合作夥伴關係與合作
    • 新產品發布
    • 擴張計劃

第5章:市場估計與預測:依治療機制分類,2025-2034年

  • 主要趨勢
  • 外在自癒系統
    • 基於膠囊的系統
    • 血管系統
  • 內在自癒系統
    • 可逆共價鍵
    • 超分子/非共價鍵

第6章:市場估算與預測:依應用領域分類,2025-2034年

  • 主要趨勢
  • 結構部件
    • 機身和機身面板
    • 機翼結構
    • 控制面
    • 引擎室
  • 非結構性和半結構性零件
    • 內部組件
    • 雷達罩
    • 整流罩和檢修面板
  • 塗層和表面
    • 耐侵蝕及耐腐蝕塗層
    • 耐刮且美觀的塗層
  • 功能組件

第7章:市場估算與預測:依最終用途分類,2025-2034年

  • 主要趨勢
  • 商業航空
    • 窄體飛機
    • 寬體飛機
    • 支線噴射機
  • 軍事與國防
    • 戰鬥機
    • 運輸和貨運飛機
  • 無人駕駛飛行器(UAV)
    • 通用航空
    • 公務機
    • 私人飛機
  • 空間系統

第8章:市場估算與預測:依地區分類,2025-2034年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第9章:公司簡介

  • SCHOTT Pharma AG & Co. KGaA
  • Gerresheimer AG
  • Stevanato Group SpA
  • West Pharmaceutical Services, Inc.
  • Becton, Dickinson and Company (BD)
  • Ypsomed AG
  • Owen Mumford Ltd.
  • SHL Medical AG
  • Haselmeier GmbH
  • Phillips-Medisize (a Molex company)
  • Nemera
  • Credence MedSystems, Inc.
  • Terumo Corporation
  • Kraton Corporation
  • Datwyler Holding Inc.
簡介目錄
Product Code: 14858

The Global Self-Healing Polymers for Aerospace Applications Market was valued at USD 175 million in 2024 and is estimated to grow at a CAGR of 13.2% to reach USD 603.2 million by 2034.

Self-Healing Polymers for Aerospace Applications Market - IMG1

The growth is driven by advancements in polymer technology aimed at improving aircraft maintenance. Self-healing polymers are becoming increasingly important in aerospace as they are designed to repair micro-cracks and damage before it is visible to inspectors, reducing the need for frequent maintenance. These technologies, such as capsule-filled epoxies, vascular carbon-fiber reinforced polymers (CFRPs), and dynamic covalent thermoplastics, are proving effective in extending the life cycle of aircraft parts. The adoption of self-healing systems has expanded from coatings to critical structural components, and major aerospace players are now exploring their integration directly into primary structures to improve durability and reduce weight. As regulations become stricter, especially regarding the environmental impact of aerospace materials, the demand for self-healing polymers continues to rise. The latest sustainable aviation initiatives, such as the EU's roadmap targeting 50% composite recyclability by 2035, are further propelling market growth.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$175 Million
Forecast Value$603.2 Million
CAGR13.2%

The extrinsic self-healing systems segment is forecasted to grow at a CAGR of 13% from 2025 to 2034. This segment benefits from a hybrid approach that combines capsule, vascular, and intrinsic systems, offering a more durable and manufacturable solution that reduces aircraft inspection intervals by up to 15%. This integrated system is poised to become a standard feature in next-generation narrow-body aircraft expected to launch in 2028.

The commercial aviation segment was valued at USD 89.7 million in 2024. The integration of self-healing technology into structural components during early production stages is gaining momentum. The adoption of self-healing polymers is increasingly driven by production-rate increases, digital twin models, and stricter damage-tolerance regulations. By incorporating self-healing materials from the outset, OEMs can achieve more predictable repair cycles and long-term cost savings.

North America Self-Healing Polymers for Aerospace Applications Market generated USD 65.9 million in 2024 and is expected to reach USD 219.8 million by 2034. The primary driver is the growing demand from the aerospace industry, particularly in the U.S., which accounted for USD 56.5 million in 2024. This market is benefiting from a robust commercial aircraft production sector, alongside the U.S. military's push for condition-based maintenance. The adoption of advanced self-healing technologies is being accelerated by tax incentives, research grants, and a well-established maintenance, repair, and overhaul (MRO) network.

The leading companies in the Global Self-Healing Polymers for Aerospace Applications Market include Autonomic Materials Inc., Arkema, Evonik Industries AG, BASF SE, and Solvay SA. To enhance their market position, companies are pursuing multiple strategies, including investing heavily in R&D to develop more efficient and cost-effective self-healing polymer technologies. They are also focusing on expanding their product offerings by integrating self-healing materials directly into primary aircraft structures, thereby improving durability, reducing weight, and increasing manufacturing efficiency. Strategic partnerships with aerospace OEMs and suppliers are being forged to ensure the seamless integration of self-healing systems into aircraft production lines. Furthermore, these companies are actively working to meet stringent environmental and regulatory standards, such as recyclability goals, by developing sustainable, bio-based materials.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Healing Mechanism
    • 2.2.3 Application
    • 2.2.4 End Use
  • 2.3 TAM Analysis, 2025-2034
  • 2.4 CXO perspectives: Strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Future Outlook and Strategic Recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier Landscape
    • 3.1.2 Profit Margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rise in biologics and biosimilars
      • 3.2.1.2 Self-administration & home care
      • 3.2.1.3 Regulatory push for syringe safety
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Glass delamination & breakage
      • 3.2.2.2 Stringent regulatory testing
      • 3.2.2.3 Supply chain complexity
    • 3.2.3 Market opportunities
      • 3.2.3.1 Polymer material innovation
      • 3.2.3.2 Smart/connected syringe systems
      • 3.2.3.3 Demand in APAC emerging markets
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis
    • 3.6.1 Technology and Innovation landscape
    • 3.6.2 Current technological trends
    • 3.6.3 Emerging technologies
  • 3.7 Price trends
    • 3.7.1 By region
    • 3.7.2 By Healing Mechanism
  • 3.8 Future market trends
  • 3.9 Patent Landscape
  • 3.10 Trade statistics (HS code) (Note: the trade statistics will be provided for key countries only)
    • 3.10.1 Major importing countries
    • 3.10.2 Major exporting countries
  • 3.11 Sustainability and Environmental Aspects
    • 3.11.1 Sustainable Practices
    • 3.11.2 Waste Reduction Strategies
    • 3.11.3 Energy Efficiency in Production
    • 3.11.4 Eco-friendly Initiatives
  • 3.12 Carbon Footprint Considerations

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 LATAM
      • 4.2.1.5 MEA
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New Product Launches
    • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Healing Mechanism, 2025 - 2034 (USD Million, Tons)

  • 5.1 Key trends
  • 5.2 Extrinsic self-healing systems
    • 5.2.1 Capsule-based systems
    • 5.2.2 Vascular systems
  • 5.3 Intrinsic self-healing systems
    • 5.3.1 Reversible covalent bonds
    • 5.3.2 Supramolecular / non-covalent bonds

Chapter 6 Market Estimates and Forecast, By Application, 2025 - 2034 (USD Million, Tons)

  • 6.1 Key trends
  • 6.2 Structural components
    • 6.2.1 Fuselage and airframe panels
    • 6.2.2 Wing structures
    • 6.2.3 Control surfaces
    • 6.2.4 Engine nacelles
  • 6.3 Non-structural & semi-structural components
    • 6.3.1 Interior components
    • 6.3.2 Radomes
    • 6.3.3 Fairings and access panels
  • 6.4 Coatings & surfaces
    • 6.4.1 Erosion and corrosion resistant coatings
    • 6.4.2 Scratch-resistant & aesthetic coatings
  • 6.5 Functional components

Chapter 7 Market Estimates and Forecast, By End Use, 2025 - 2034 (USD Million, Tons)

  • 7.1 Key trends
  • 7.2 Commercial aviation
    • 7.2.1 Narrow-body aircraft
    • 7.2.2 Wide-body aircraft
    • 7.2.3 Regional jets
  • 7.3 Military & defense
    • 7.3.1 Fighter jets
    • 7.3.2 Transport & cargo aircraft
  • 7.4 Unmanned aerial vehicles (UAVs)
    • 7.4.1 General aviation
    • 7.4.2 Business jets
    • 7.4.3 Private aircraft
  • 7.5 Space systems

Chapter 8 Market Estimates and Forecast, By Region, 2025 - 2034 (USD Million, Tons)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 SCHOTT Pharma AG & Co. KGaA
  • 9.2 Gerresheimer AG
  • 9.3 Stevanato Group S.p.A.
  • 9.4 West Pharmaceutical Services, Inc.
  • 9.5 Becton, Dickinson and Company (BD)
  • 9.6 Ypsomed AG
  • 9.7 Owen Mumford Ltd.
  • 9.8 SHL Medical AG
  • 9.9 Haselmeier GmbH
  • 9.10 Phillips-Medisize (a Molex company)
  • 9.11 Nemera
  • 9.12 Credence MedSystems, Inc.
  • 9.13 Terumo Corporation
  • 9.14 Kraton Corporation
  • 9.15 Datwyler Holding Inc.